Schonfeld Strategic Advisors LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$217,000
-82.6%
1,000
-90.7%
0.00%
-82.4%
Q4 2020$1,247,000
+374.1%
10,800
+300.0%
0.02%
+240.0%
Q3 2020$263,000
-92.1%
2,700
-90.1%
0.01%
-88.9%
Q2 2020$3,340,000
+52.9%
27,210
+30.2%
0.04%
-15.1%
Q4 2019$2,185,000
-44.3%
20,900
-38.7%
0.05%
-53.9%
Q3 2019$3,922,000
+31.5%
34,100
+97.1%
0.12%
+9.5%
Q2 2019$2,983,000
-78.9%
17,300
-79.4%
0.10%
-78.6%
Q1 2019$14,127,000
+91.6%
83,800
+10.7%
0.49%
+73.5%
Q4 2018$7,372,000
-47.1%
75,700
-6.2%
0.28%
-54.4%
Q3 2018$13,940,000
+22.4%
80,700
-1.1%
0.62%
+0.5%
Q2 2018$11,387,000
+62.3%
81,600
+31.0%
0.62%
+17.3%
Q1 2018$7,016,000
-34.8%
62,271
-23.5%
0.53%
-40.2%
Q4 2017$10,753,000
+260.4%
81,453
+177.0%
0.88%
+223.5%
Q3 2017$2,984,000
-53.9%
29,404
-54.5%
0.27%
-59.2%
Q2 2017$6,472,000
+1.7%
64,555
+22.7%
0.67%
+4.5%
Q1 2017$6,365,000
+87.8%
52,627
+73.5%
0.64%
+45.3%
Q4 2016$3,389,000
+239.9%
30,326
+304.1%
0.44%
+159.8%
Q3 2016$997,0007,5040.17%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2018
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders